Current knowledge and pharmacological profile of berberine: An update - PubMed (original) (raw)
Review
. 2015 Aug 15:761:288-97.
doi: 10.1016/j.ejphar.2015.05.068. Epub 2015 Jun 16.
Affiliations
- PMID: 26092760
- DOI: 10.1016/j.ejphar.2015.05.068
Review
Current knowledge and pharmacological profile of berberine: An update
Anil Kumar et al. Eur J Pharmacol. 2015.
Abstract
Berberine, a benzylisoquinoline alkaloid, occurs as an active constituent in numerous medicinal plants and has an array of pharmacological properties. It has been used in Ayurvedic and Chinese medicine for its antimicrobial, antiprotozoal, antidiarrheal and antitrachoma activity. Moreover, several clinical and preclinical studies demonstrate ameliorative effect of berberine against several disorders including metabolic, neurological and cardiological problems. This review provides a summary regarding the pharmacokinetic and pharmacodynamic features of berberine, with a focus on the different mechanisms underlying its multispectrum activity. Studies regarding the safety profile, drug interactions and important clinical trials of berberine have also been included. Clinical trials with respect to neurological disorders need to be undertaken to exploit the beneficiary effects of berberine against serious disorders such as Alzheimer's and Parkinson's disease. Also, clinical studies to detect rare adverse effects of berberine need to be initiated to draw a complete safety profile of berberine and strengthen its applicability.
Keywords: 5-hydroxytryptamine (PubChem CID: 5202); 6-OHDA (PubChem CID: 4624); Berbamine (PubChem CID: 10170); Berberine; Berberine (PubChem CID: 2353); Berberrubine (PubChem CID: 72704); Daunomycin (PubChem CID: 30323); Immunomodulation; Jatrorrhizine (PubChem CID: 72323); Mitoxantrone (PubChem CID: 4212); Oxidative stress; Pharmacodynamics; Pharmacokinetics; Streptazotocin (PubChem CID: 29327); Thalifendine (PubChem CID: 3084288); Verapamil (PubChem CID: 2520).
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
- Finding new sources from "using different plants as the same herb": A case study of Huang-lian in Northwest Yunnan, China.
Zhang Y, Geng YF, Zhang LL, Wang L, He LJ, Wang C, Chai ZZ, Fan RY, Li S, Wang YH. Zhang Y, et al. J Ethnopharmacol. 2015 Jul 1;169:413-25. doi: 10.1016/j.jep.2015.04.051. Epub 2015 May 6. J Ethnopharmacol. 2015. PMID: 25956675 - Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Fang Y, Zhang J, Zhu S, He M, Ma S, Jia Q, Sun Q, Song L, Wang Y, Duan L. Fang Y, et al. Pharmacol Res. 2021 Mar;165:105439. doi: 10.1016/j.phrs.2021.105439. Epub 2021 Jan 22. Pharmacol Res. 2021. PMID: 33493658 - Carboxymethyl cellulose-based hydrogel film combined with berberine as an innovative tool for chronic wound management.
Cometa S, Licini C, Bonifacio MA, Mastrorilli P, Mattioli-Belmonte M, De Giglio E. Cometa S, et al. Carbohydr Polym. 2022 May 1;283:119145. doi: 10.1016/j.carbpol.2022.119145. Epub 2022 Jan 22. Carbohydr Polym. 2022. PMID: 35153024 - Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
Kulkarni SK, Dhir A. Kulkarni SK, et al. Phytother Res. 2010 Mar;24(3):317-24. doi: 10.1002/ptr.2968. Phytother Res. 2010. PMID: 19998323 Review. - Berberine: a potential phytochemical with multispectrum therapeutic activities.
Vuddanda PR, Chakraborty S, Singh S. Vuddanda PR, et al. Expert Opin Investig Drugs. 2010 Oct;19(10):1297-307. doi: 10.1517/13543784.2010.517745. Expert Opin Investig Drugs. 2010. PMID: 20836620 Review.
Cited by
- Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017-2023).
Valipour M, Zakeri Khatir Z, Abdollahi E, Ayati A. Valipour M, et al. ACS Pharmacol Transl Sci. 2023 Dec 28;7(1):48-71. doi: 10.1021/acsptsci.3c00292. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2023. PMID: 38230282 Free PMC article. Review. - Understanding the ultrastructural aspects of berberine-induced skin-darkening activity in the toad, Bufo melanostictus, melanophores.
Ali SA, Naaz I. Ali SA, et al. J Microsc Ultrastruct. 2015 Oct-Dec;3(4):210-219. doi: 10.1016/j.jmau.2015.07.001. Epub 2015 Aug 5. J Microsc Ultrastruct. 2015. PMID: 30023201 Free PMC article. - In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.
Choudhury D, Jala A, Murty US, Borkar RM, Banerjee S. Choudhury D, et al. AAPS PharmSciTech. 2022 Mar 16;23(4):89. doi: 10.1208/s12249-022-02241-9. AAPS PharmSciTech. 2022. PMID: 35296955 Free PMC article. - Berberine Alleviates Amyloid _β_-Induced Mitochondrial Dysfunction and Synaptic Loss.
Zhao C, Su P, Lv C, Guo L, Cao G, Qin C, Zhang W. Zhao C, et al. Oxid Med Cell Longev. 2019 May 2;2019:7593608. doi: 10.1155/2019/7593608. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31191803 Free PMC article. - A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine.
Liu D, Meng X, Wu D, Qiu Z, Luo H. Liu D, et al. Front Pharmacol. 2019 Feb 14;10:9. doi: 10.3389/fphar.2019.00009. eCollection 2019. Front Pharmacol. 2019. PMID: 30837865 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources